Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US

FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

The Madness of Pop Psychiatry - by Nick Jikomes, PhD

FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation